| Property | Value |
|---|
|
?:abstract
|
-
Martinez-Lamas et al. (2020) provide some preliminary findings on the potential use of povidone-iodine for reducing oropharyngeal viral load of SARS-CoV-2. Chin et al. (2020) have also proposed some efficacy for the antiviral properties of povidone-iodine in another context. Both of these findings offer some promise for implementing povidone-iodine as a tool for prevention. Their findings are also consistent with the use of halogens generally as coronavirus antivirals (Cimolai 2020a). The use of RT-PCR as the tool to assess viral load nevertheless has some potential limitations. Although clinical samples are often extracted prior to amplification, a number of inhibitors may be present that may not be removed sufficiently.
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/7c3ea454a5d0d4abf15434f402af72c0e5832f34.json
|
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7405470.xml.json
|
|
?:pmcid
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
Efficacy of povidone‐iodine to reduce viral load
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}